EPA055	Characterization of Hiv-1 intact and near-full length defective proviral populations during long-term suppression on antiretroviral therapy	E-poster	Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus
EPA003	Characterization of novel candidate factors impacting HIV life cycle	E-poster	HIV biology (entry, replicative cycle, transcriptional expression and regulation)
EPA094	Characterization of serum and mucosal SARS-CoV-2-antibodies in HIV-1 infected subjects after BNT162b2 mRNA vaccination or SARS-CoV-2 infection	E-poster	SARS-Cov2 vaccines
EPB173	Characterization of the absorption, metabolism, and excretion of islatravir, an HIV nucleoside reverse transcriptase translocation inhibitor, in humans	E-poster	Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring
EPD560	Characterization of the microbiome in breast cancer patients diagnosed with COVID-19	E-poster	Effects of the COVID-19 on key populations
EPA034	Characterization of tissue-resident CD8 T-cells in the pulmonary mucosa of people living with HIV on long-term ART	E-poster	Mucosal immunity
EPC443	Characterizing COVID-19 outcomes among PLHIV in India: findings from community-based national survey	E-poster	Epidemiology of COVID-19 among persons living with HIV and / or including tuberculosis
EPC286	Characterizing history of opioid agonist therapy uptake among people who inject drugs in Iran: findings from a national bio-behavioral surveillance survey in 2020	E-poster	Access to harm reduction interventions
OAD0304	Characterizing substance use typologies and their association with sexual risk behaviors: a latent class analysis among men who have sex with men in Mexico	Oral abstract session with live Q&A	Gay men other men who have sex with men
EPA026	Characterizing the effect of intracellular storage pools of RANTES/CCL5 on HIV infection in macrophages	E-poster	Innate immunity (including NK cells)